GUARDIAN DRUG COMPANY
Dead / Cancelled — Cancelled — Section 8 (as of 16 Jan 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88177936
- Registration number
- 5792655
- Mark type
- Design + words
- Filed
- 01 Nov 2018
- Published for opposition
- 16 Apr 2019
- Registered
- 02 Jul 2019
- Attorney of record
- Daniel S. Kirshner
Goods and services
- Class 005 — Pharmaceuticals: Antacids; Laxatives; Cough and sinus congestion treatment preparations; Nausea treatment preparations; Diarrhea medication; Anti-flatulent preparations; Dietary fiber to aid digestion; Sleep aid preparations in the nature of sleep aid tablets; Bismuth preparations for pharmaceutical purposes; Probiotic preparations for medical use; Allergy medications; Preparation for the relief of pain; Preparations for treating colds; Pharmaceutical preparations for treating lactose intolerance
Owner
- Guardian Drug Company, Dayton, NJ, US
- Guardian Drug Company, Dayton, NJ, US
- Guardian Drug Company, Dayton, NJ, US
Prosecution history
- 16 Jan 2026 — CANCELLED SEC. 8 (6-YR)
- 02 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2019 — PUBLISHED FOR OPPOSITION
- 27 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2019 — ASSIGNED TO LIE
- 15 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Feb 2019 — EXAMINER'S AMENDMENT ENTERED
- 15 Feb 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Feb 2019 — EXAMINERS AMENDMENT E-MAILED
- 15 Feb 2019 — EXAMINERS AMENDMENT -WRITTEN
- 12 Feb 2019 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 12 Feb 2019 — PRIORITY ACTION E-MAILED
- 12 Feb 2019 — PRIORITY ACTION WRITTEN